Antihypertensive, Drug Exposure

Simple item page
dc.contributor.advisorUtidjian, Levon
dc.contributor.authorUtidjian, Levon
dc.contributor.otherChildren's Hospital of Philadelphia
dc.date.accessioned2024-06-10T19:03:14Z
dc.date.available2024-06-10T19:03:14Z
dc.date.created2021-03-01
dc.descriptionThis medication concept set includes the following ingredients: ambrisentan, bethanidine, bosentan, cadralazine, clonidine, debrisoquin, deserpidine, diazoxide, dihydralazine, doxazosin, guanethidine, Guanoxan, hydralazine, indoramin, ketanserin, macitentan, mecamylamine, methoserpidine, methyldopa, metyrosine, minoxidil, moxonidine, nitroprusside, pargyline, pinacidil, prazosin, Rauwolfia preparation, rescinnamine, reserpine, rilmenidine, riociguat, Sitaxentan, tadalafil, Trimazosin, trimethaphan, urapidil, veratrum. It also includes combinations of these ingredients with other antihypertensive medications. This code list was generated by taking the descendants of all the 'other' antihypertensive ingredients of interest, and also doing string matching on the concept_name of the ingredient. This broad concept set was intended to identify patients who received 'other' antihypertensive ingredient not listed as RAAS blockers, calcium channel blockers, beta-blockers, or diuretics. Limited to RxNorm and RxNorm Extension codes. Technical Note: This concept set was created when ingredients were required for some sites. It could be enhanced by using SCDF drug levels and taking descendants, which would also make this easier to refresh.
dc.description.abstractConcept set intended to identify patients with an exposure to an antihypertensive medication.
dc.identifier.urihttps://pedsnet.org/metadata/handle/20.500.14642/411
dc.provenanceTreatment of Henoch-Schonlein purpura (HSP) Nephritis
dc.publisherPEDSnet
dc.relation.isreferencedbyStone HK, Mitsnefes M, Dickinson K, et al. 2023. "Clinical course and management of children with IgA vasculitis with nephritis." _Pediatr Nephrol_ 38, 3721�3733. <br>DOI: [10.1007/s00467-023-06023-8](https://doi.org/10.1007/s00467-023-06023-8)
dc.rightsa CC-BY Attribution 4.0 License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectConcept Set Development::Content Data Model::PEDSnet Data Model
dc.subjectConcept Set Development::Concept Set Evaluation::Clinician Reviewed
dc.subjectConcept Set Development::Concept Set Development Strategy::Broad
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Component
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Component
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Multiple Ingredients
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Precise Ingredient
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Ingredient
dc.subject.meshAngiotensin Converting Enzyme Inhibitor
dc.subject.meshThiazide Diuretic
dc.subject.meshCalcium Channel Blocker
dc.subject.otherRxNorm
dc.subject.otherRxNorm Extension
dc.titleAntihypertensive, Drug Exposure
dspace.entity.typeConceptSet
local.quality.statusNeeds Refinement
local.subject.DataModelPEDSnet Data Model
local.subject.EvalTypeClinician Reviewed
local.subject.MedTermCharBrand Pack Name
local.subject.MedTermCharSemantic Branded Drug
local.subject.MedTermCharSemantic Clinical Drug
local.subject.MedTermCharSemantic Branded Drug Form
local.subject.MedTermCharSemantic Clinical Drug Form
local.subject.MedTermCharSemantic Branded Drug Component
local.subject.MedTermCharSemantic Clinical Drug Component
local.subject.MedTermCharMultiple Ingredients
local.subject.MedTermCharPrecise Ingredient
local.subject.MedTermCharIngredient
local.subject.flatBroad
local.variable.namerx_antihyp
relation.isStudyOfConceptSet9e8d04a8-d5be-4bd8-a904-c533a7dcd490
relation.isStudyOfConceptSet.latestForDiscovery9e8d04a8-d5be-4bd8-a904-c533a7dcd490

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
rx_2021_03_Antihypertensive_V1.csv
Size:
2.06 MB
Format:
Comma-Separated Values
Download

Domains

Medication Concept Sets